Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 47

1.

Dynamics of B Cell Recovery In Kidney/Bone Marrow Transplant Recipients.

Gao B, Gu Y, Rong C, Moore C, Porcheray F, Wong W, Preffer F, Saidman SL, Fu Y, Cosimi B, Sachs DH, Kawai T, Sykes M, Zorn E.

Transplantation. 2017 Nov;101(11):2722-2730. doi: 10.1097/TP.0000000000001789.

2.

Evidence to Support a Contribution of Polyreactive Antibodies to HLA Serum Reactivity.

Gao B, Rong C, Porcheray F, Moore C, Girouard TC, Saidman SL, Wong W, Fu Y, Zorn E.

Transplantation. 2016 Jan;100(1):217-26. doi: 10.1097/TP.0000000000000840.

3.

Anti-HLA antibody testing in hematology patients.

Peña JR, Saidman SL.

Am J Hematol. 2015 Apr;90(4):361-4. doi: 10.1002/ajh.23935. Review.

4.

Concordance and discordance in anti-HLA antibody testing.

Israeli M, Pollack MS, Shaut CA, Halpin A, DiPaola NR, Youngs D, Saidman SL; ASHI Proficiency Testing Program.

Transpl Immunol. 2015 Jan;32(1):1-8. doi: 10.1016/j.trim.2014.10.003. Epub 2014 Oct 18.

PMID:
25460810
5.

Pretransplant IgG reactivity to apoptotic cells correlates with late kidney allograft loss.

Gao B, Moore C, Porcheray F, Rong C, Abidoglu C, DeVito J, Paine R, Girouard TC, Saidman SL, Schoenfeld D, Levin B, Wong W, Elias N, Schuetz C, Rosales I, Fu Y, Zorn E.

Am J Transplant. 2014 Jul;14(7):1581-91. doi: 10.1111/ajt.12763. Epub 2014 Jun 16.

6.

Long-term results in recipients of combined HLA-mismatched kidney and bone marrow transplantation without maintenance immunosuppression.

Kawai T, Sachs DH, Sprangers B, Spitzer TR, Saidman SL, Zorn E, Tolkoff-Rubin N, Preffer F, Crisalli K, Gao B, Wong W, Morris H, LoCascio SA, Sayre P, Shonts B, Williams WW Jr, Smith RN, Colvin RB, Sykes M, Cosimi AB.

Am J Transplant. 2014 Jul;14(7):1599-611. doi: 10.1111/ajt.12731. Epub 2014 Jun 5.

7.

Anti-HLA alloantibodies in surgical patients refractory to platelet transfusion.

Peña JR, Saidman SL, Girouard TC, Meister E, Dzik WH, Makar RS.

Am J Hematol. 2014 Sep;89(9):E133-7. doi: 10.1002/ajh.23757. Epub 2014 Jun 19.

8.

Polyreactive antibodies developing amidst humoral rejection of human kidney grafts bind apoptotic cells and activate complement.

Porcheray F, Fraser JW, Gao B, McColl A, DeVito J, Dargon I, Helou Y, Wong W, Girouard TC, Saidman SL, Colvin RB, Palmisano A, Maggiore U, Vaglio A, Smith RN, Zorn E.

Am J Transplant. 2013 Oct;13(10):2590-600. doi: 10.1111/ajt.12394. Epub 2013 Aug 6.

9.

Complement-dependent cytotoxicity crossmatch.

Peña JR, Fitzpatrick D, Saidman SL.

Methods Mol Biol. 2013;1034:257-83. doi: 10.1007/978-1-62703-493-7_13.

PMID:
23775741
10.

Expansion of polyreactive B cells cross-reactive to HLA and self in the blood of a patient with kidney graft rejection.

Porcheray F, DeVito J, Helou Y, Dargon I, Fraser JW, Nobecourt P, Ferdman J, Germana S, Girouard TC, Kawai T, Saidman SL, Wong W, Colvin RB, Leguern C, Zorn E.

Am J Transplant. 2012 Aug;12(8):2088-97. doi: 10.1111/j.1600-6143.2012.04053.x. Epub 2012 Apr 17.

11.

Mixed chimerism, lymphocyte recovery, and evidence for early donor-specific unresponsiveness in patients receiving combined kidney and bone marrow transplantation to induce tolerance.

LoCascio SA, Morokata T, Chittenden M, Preffer FI, Dombkowski DM, Andreola G, Crisalli K, Kawai T, Saidman SL, Spitzer TR, Tolkoff-Rubin N, Cosimi AB, Sachs DH, Sykes M.

Transplantation. 2010 Dec 27;90(12):1607-15. doi: 10.1097/TP.0b013e3181ffbaff.

12.

Analysis of cutoffs for screening sensitized blood donors for HLA alloantibodies using a cytometric microbead assay.

Makar RS, Saidman SL, Stowell CP, Lee H, Powers A.

Transfusion. 2011 Jan;51(1):166-74. doi: 10.1111/j.1537-2995.2010.02771.x.

PMID:
20633246
13.

Chronic humoral rejection of human kidney allografts associates with broad autoantibody responses.

Porcheray F, DeVito J, Yeap BY, Xue L, Dargon I, Paine R, Girouard TC, Saidman SL, Colvin RB, Wong W, Zorn E.

Transplantation. 2010 May 27;89(10):1239-46. doi: 10.1097/TP.0b013e3181d72091.

14.

B-cell immunity in the context of T-cell tolerance after combined kidney and bone marrow transplantation in humans.

Porcheray F, Wong W, Saidman SL, De Vito J, Girouard TC, Chittenden M, Shaffer J, Tolkoff-Rubin N, Dey BR, Spitzer TR, Colvin RB, Cosimi AB, Kawai T, Sachs DH, Sykes M, Zorn E.

Am J Transplant. 2009 Sep;9(9):2126-35. doi: 10.1111/j.1600-6143.2009.02738.x. Epub 2009 Jul 16.

15.

Multicenter evaluation of a novel endothelial cell crossmatch test in kidney transplantation.

Breimer ME, Rydberg L, Jackson AM, Lucas DP, Zachary AA, Melancon JK, Von Visger J, Pelletier R, Saidman SL, Williams WW Jr, Holgersson J, Tydén G, Klintmalm GK, Coultrup S, Sumitran-Holgersson S, Grufman P.

Transplantation. 2009 Feb 27;87(4):549-56. doi: 10.1097/TP.0b013e3181949d4e.

PMID:
19307793
16.

Bortezomib in kidney transplant recipients with antibody mediated rejection: three case reports.

Wong W, Lee RA, Saidman SL, Smith RN, Zorn E.

Clin Transpl. 2009:401-5.

17.

Testing only donors with a prior history of pregnancy or transfusion is a logical and cost-effective transfusion-related acute lung injury prevention strategy.

Powers A, Stowell CP, Dzik WH, Saidman SL, Lee H, Makar RS.

Transfusion. 2008 Dec;48(12):2549-58. doi: 10.1111/j.1537-2995.2008.01902.x. Epub 2008 Aug 20.

PMID:
18717778
18.

Clinical outcomes of late rather than early full-donor chimerism in patients with advanced lymphomas receiving nonmyeloablative allogeneic hematopoietic SCT.

Ting DT, Spitzer TR, Chaudhary A, Muzikansky A, Colby C, Power K, McAfee S, Ballen K, Attar E, Saidman SL, Preffer F, Sykes M, Dey BR.

Bone Marrow Transplant. 2008 Sep;42(5):329-35. doi: 10.1038/bmt.2008.167. Epub 2008 Jun 30.

PMID:
18587439
19.

HLA-mismatched renal transplantation without maintenance immunosuppression.

Kawai T, Cosimi AB, Spitzer TR, Tolkoff-Rubin N, Suthanthiran M, Saidman SL, Shaffer J, Preffer FI, Ding R, Sharma V, Fishman JA, Dey B, Ko DS, Hertl M, Goes NB, Wong W, Williams WW Jr, Colvin RB, Sykes M, Sachs DH.

N Engl J Med. 2008 Jan 24;358(4):353-61. doi: 10.1056/NEJMoa071074.

20.
21.

Histocompatibility testing for highly sensitized transplant candidates.

Saidman SL.

Transplant Proc. 2007 Apr;39(3):673-5.

PMID:
17445570
22.

Putative antibody-mediated rejection with C4d deposition in HLA-identical, ABO-compatible renal allografts.

Collins AB, Chicano SL, Cornell LD, Tolkoff-Rubin N, Goes NB, Saidman SL, Farrell ML, Cosimi AB, Colvin RB.

Transplant Proc. 2006 Dec;38(10):3427-9.

PMID:
17175293
23.

Utilizing list exchange and nondirected donation through 'chain' paired kidney donations.

Roth AE, Sönmez T, Unver MU, Delmonico FL, Saidman SL.

Am J Transplant. 2006 Nov;6(11):2694-705. Epub 2006 Sep 18.

24.

Allosensitization does not increase the risk of xenoreactivity to alpha1,3-galactosyltransferase gene-knockout miniature swine in patients on transplantation waiting lists.

Wong BS, Yamada K, Okumi M, Weiner J, O'Malley PE, Tseng YL, Dor FJ, Cooper DK, Saidman SL, Griesemer A, Sachs DH.

Transplantation. 2006 Aug 15;82(3):314-9.

PMID:
16906027
25.

Myeloma responses and tolerance following combined kidney and nonmyeloablative marrow transplantation: in vivo and in vitro analyses.

Fudaba Y, Spitzer TR, Shaffer J, Kawai T, Fehr T, Delmonico F, Preffer F, Tolkoff-Rubin N, Dey BR, Saidman SL, Kraus A, Bonnefoix T, McAfee S, Power K, Kattleman K, Colvin RB, Sachs DH, Cosimi AB, Sykes M.

Am J Transplant. 2006 Sep;6(9):2121-33. Epub 2006 Jun 22.

26.

Increasing the opportunity of live kidney donation by matching for two- and three-way exchanges.

Saidman SL, Roth AE, Sönmez T, Unver MU, Delmonico FL.

Transplantation. 2006 Mar 15;81(5):773-82.

PMID:
16534482
27.

Prevalence and significance of anti-HLA and donor-specific antibodies long-term after renal transplantation.

Cardarelli F, Pascual M, Tolkoff-Rubin N, Delmonico FL, Wong W, Schoenfeld DA, Zhang H, Cosimi AB, Saidman SL.

Transpl Int. 2005 May;18(5):532-40.

28.

Interferon-alpha therapy in liver transplant recipients: lack of association with increased production of anti-HLA antibodies.

Cardarelli F, Pascual M, Chung RT, Tolkoff-Rubin N, Wong W, Cosimi AB, Saidman SL.

Am J Transplant. 2004 Aug;4(8):1352-6.

29.

Analysis of the cardiovascular risk profile in stable kidney transplant recipients after 50% cyclosporine reduction.

Wong W, Tolkoff-Rubin N, Delmonico FL, Cardarelli F, Saidman SL, Farrell ML, Shih V, Winkelmayer WC, Cosimi AB, Pascual M.

Clin Transplant. 2004 Aug;18(4):341-8.

PMID:
15233807
30.

Alloantibody and xenoantibody cross-reactivity in transplantation.

Cooper DK, Tseng YL, Saidman SL.

Transplantation. 2004 Jan 15;77(1):1-5. Review.

PMID:
14724427
31.

NK cell recovery, chimerism, function, and recognition in recipients of haploidentical hematopoietic cell transplantation following nonmyeloablative conditioning using a humanized anti-CD2 mAb, Medi-507.

Koenecke C, Shaffer J, Alexander SI, Preffer F, Dombkowski D, Saidman SL, Dey B, McAfee S, Spitzer TR, Sykes M.

Exp Hematol. 2003 Oct;31(10):911-23.

PMID:
14550807
32.

Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease.

Bühler LH, Spitzer TR, Sykes M, Sachs DH, Delmonico FL, Tolkoff-Rubin N, Saidman SL, Sackstein R, McAfee S, Dey B, Colby C, Cosimi AB.

Transplantation. 2002 Nov 27;74(10):1405-9.

PMID:
12451240
33.

Acute humoral rejection in kidney transplantation: II. Morphology, immunopathology, and pathologic classification.

Mauiyyedi S, Crespo M, Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Tolkoff-Rubin NE, Williams WW, Delmonico FL, Cosimi AB, Colvin RB.

J Am Soc Nephrol. 2002 Mar;13(3):779-87.

34.

Managing the highly sensitized transplant recipient and B cell tolerance.

Baid S, Saidman SL, Tolkoff-Rubin N, Williams WW, Delmonico FL, Cosimi AB, Pascual M.

Curr Opin Immunol. 2001 Oct;13(5):577-81. Review.

PMID:
11544007
35.

Control of antidonor antibody production with tacrolimus and mycophenolate mofetil in renal allograft recipients with chronic rejection.

Theruvath TP, Saidman SL, Mauiyyedi S, Delmonico FL, Williams WW, Tolkoff-Rubin N, Collins AB, Colvin RB, Cosimi AB, Pascual M.

Transplantation. 2001 Jul 15;72(1):77-83.

PMID:
11468538
36.

Acute humoral rejection in renal allograft recipients: I. Incidence, serology and clinical characteristics.

Crespo M, Pascual M, Tolkoff-Rubin N, Mauiyyedi S, Collins AB, Fitzpatrick D, Farrell ML, Williams WW, Delmonico FL, Cosimi AB, Colvin RB, Saidman SL.

Transplantation. 2001 Mar 15;71(5):652-8.

PMID:
11292296
37.

Graft-versus-tumor induction with donor leukocyte infusions as primary therapy for patients with malignancies.

Porter DL, Connors JM, Van Deerlin VM, Duffy KM, McGarigle C, Saidman SL, Leonard DG, Antin JH.

J Clin Oncol. 1999 Apr;17(4):1234.

PMID:
10561184
38.

Complement activation in acute humoral renal allograft rejection: diagnostic significance of C4d deposits in peritubular capillaries.

Collins AB, Schneeberger EE, Pascual MA, Saidman SL, Williams WW, Tolkoff-Rubin N, Cosimi AB, Colvin RB.

J Am Soc Nephrol. 1999 Oct;10(10):2208-14.

39.

Mixed lymphohaemopoietic chimerism and graft-versus-lymphoma effects after non-myeloablative therapy and HLA-mismatched bone-marrow transplantation.

Sykes M, Preffer F, McAfee S, Saidman SL, Weymouth D, Andrews DM, Colby C, Sackstein R, Sachs DH, Spitzer TR.

Lancet. 1999 May 22;353(9166):1755-9.

PMID:
10347989
40.

Accelerated acute rejection of an apparent A2 renal allograft in an O recipient: report of a case with flow cytometric analysis.

Pins MR, Saidman SL, Cosimi AB, Jennings LD, Stowell CP.

Transplantation. 1997 Apr 15;63(7):984-8.

PMID:
9112352
41.

HLA typing in patients with ocular manifestations of Stevens-Johnson syndrome.

Power WJ, Saidman SL, Zhang DS, Vamvakas EC, Merayo-Lloves JM, Kaufman AH, Foster CS.

Ophthalmology. 1996 Sep;103(9):1406-9.

PMID:
8841298
42.

Severe systemic sclerosis with anti-topoisomerase I antibodies is associated with an HLA-DRw11 allele.

Morel PA, Chang HJ, Wilson JW, Conte C, Saidman SL, Bray JD, Tweardy DJ, Medsger TA Jr.

Hum Immunol. 1994 Jun;40(2):101-10.

PMID:
7928439
43.

Combined liver-kidney transplantation and the effect of preformed lymphocytotoxic antibodies.

Saidman SL, Duquesnoy RJ, Demetris AJ, McCauley J, Ramos H, Mazariegos G, Shapiro R, Starzl TE, Fung JJ.

Transpl Immunol. 1994;2(1):61-7.

44.

Recognition of major histocompatibility complex antigens on cultured human biliary epithelial cells by alloreactive lymphocytes.

Saidman SL, Duquesnoy RJ, Zeevi A, Fung JJ, Starzl TE, Demetris AJ.

Hepatology. 1991 Feb;13(2):239-46.

45.

Chromosomal breakpoints in cholangiocarcinoma cell lines.

Storto PD, Saidman SL, Demetris AJ, Letessier E, Whiteside TL, Gollin SM.

Genes Chromosomes Cancer. 1990 Nov;2(4):300-10.

PMID:
2176543
46.
47.

Propagation of lymphocytes infiltrating human liver allografts. Correlation with histologic diagnosis of rejection.

Saidman SL, Demetris AJ, Zeevi A, Duquesnoy RJ.

Transplantation. 1990 Jan;49(1):107-12.

PMID:
2301000

Supplemental Content

Loading ...
Support Center